Suppr超能文献

一个简化以患者为中心研究的数据收集的通用且可扩展平台:可用性和可行性研究。

A Versatile and Scalable Platform That Streamlines Data Collection for Patient-Centered Studies: Usability and Feasibility Study.

作者信息

Huang Haley, Aschettino Sofia, Lari Nasim, Lee Ting-Hsuan, Rosenberg Sarah Stothers, Ng Xinyi, Muthuri Stella, Bakshi Anirudh, Bishop Korrin, Ezzeldin Hussein

机构信息

IBM Consulting, IBM, Bethesda, MD, United States.

Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, United States.

出版信息

JMIR Form Res. 2022 Sep 14;6(9):e38579. doi: 10.2196/38579.

Abstract

BACKGROUND

The Food and Drug Administration Center for Biologics Evaluation and Research (CBER) established the Biologics Effectiveness and Safety (BEST) Initiative with several objectives, including the expansion and enhancement of CBER's access to fit-for-purpose data sources, analytics, tools, and infrastructures to improve the understanding of patient experiences with conditions related to CBER-regulated products. Owing to existing challenges in data collection, especially for rare disease research, CBER recognized the need for a comprehensive platform where study coordinators can engage with study participants and design and deploy studies while patients or caregivers could enroll, consent, and securely participate as well.

OBJECTIVE

This study aimed to increase awareness and describe the design, development, and novelty of the Survey of Health and Patient Experience (SHAPE) platform, its functionality and application, quality improvement efforts, open-source availability, and plans for enhancement.

METHODS

SHAPE is hosted in a Google Cloud environment and comprises 3 parts: the administrator application, participant app, and application programming interface. The administrator can build a study comprising a set of questionnaires and self-report entries through the app. Once the study is deployed, the participant can access the app, consent to the study, and complete its components. To build SHAPE to be scalable and flexible, we leveraged the open-source software development kit, Ionic Framework. This enabled the building and deploying of apps across platforms, including iOS, Android, and progressive web applications, from a single codebase by using standardized web technologies. SHAPE has been integrated with a leading Health Level 7 (HL7®) Fast Healthcare Interoperability Resources (FHIR®) application programming interface platform, 1upHealth, which allows participants to consent to 1-time data pull of their electronic health records. We used an agile-based process that engaged multiple stakeholders in SHAPE's design and development.

RESULTS

SHAPE allows study coordinators to plan, develop, and deploy questionnaires to obtain important end points directly from patients or caregivers. Electronic health record integration enables access to patient health records, which can validate and enhance the accuracy of data-capture methods. The administrator can then download the study data into HL7® FHIR®-formatted JSON files. In this paper, we illustrate how study coordinators can use SHAPE to design patient-centered studies. We demonstrate its broad applicability through a hypothetical type 1 diabetes cohort study and an ongoing pilot study on metachromatic leukodystrophy to implement best practices for designing a regulatory-grade natural history study for rare diseases.

CONCLUSIONS

SHAPE is an intuitive and comprehensive data-collection tool for a variety of clinical studies. Further customization of this versatile and scalable platform allows for multiple use cases. SHAPE can capture patient perspectives and clinical data, thereby providing regulators, clinicians, researchers, and patient advocacy organizations with data to inform drug development and improve patient outcomes.

摘要

背景

美国食品药品监督管理局生物制品评估和研究中心(CBER)发起了生物制品有效性和安全性(BEST)倡议,其目标包括扩大和加强CBER获取适用数据源、分析方法、工具及基础设施的能力,以增进对与CBER监管产品相关疾病患者体验的理解。鉴于数据收集方面存在的挑战,尤其是在罕见病研究中,CBER认识到需要一个综合平台,使研究协调员能够与研究参与者互动,设计并开展研究,同时患者或护理人员也能够进行注册、同意参与并安全地参与研究。

目的

本研究旨在提高对健康与患者体验调查(SHAPE)平台的认知度,并描述其设计、开发、新颖之处、功能与应用、质量改进措施、开源可用性以及改进计划。

方法

SHAPE托管于谷歌云环境中,由三部分组成:管理员应用程序、参与者应用程序和应用程序编程接口。管理员可通过该应用程序构建包含一组问卷和自我报告条目的研究。研究部署后,参与者可访问该应用程序,同意参与研究并完成其中的各个部分。为使SHAPE具有可扩展性和灵活性,我们利用了开源软件开发工具包Ionic框架。这使得通过使用标准化网络技术,能够从单一代码库跨平台构建和部署应用程序,包括iOS、安卓和渐进式网络应用程序。SHAPE已与领先的健康等级7(HL7®)快速医疗保健互操作性资源(FHIR®)应用程序编程接口平台1upHealth集成,允许参与者同意一次性提取其电子健康记录数据。我们采用了基于敏捷的流程,让多个利益相关者参与SHAPE的设计和开发。

结果

SHAPE使研究协调员能够规划、开发和部署问卷,以直接从患者或护理人员处获取重要终点数据。电子健康记录集成可访问患者健康记录,从而验证并提高数据采集方法的准确性。然后,管理员可将研究数据下载为HL7® FHIR®格式的JSON文件。在本文中,我们举例说明了研究协调员如何使用SHAPE设计以患者为中心的研究。我们通过一项假设的1型糖尿病队列研究以及一项正在进行的关于异染性脑白质营养不良的试点研究展示了其广泛适用性,以实施设计罕见病监管级自然史研究的最佳实践。

结论

SHAPE是一款适用于各种临床研究的直观且全面的数据收集工具。对这个多功能且可扩展平台的进一步定制可实现多种用例。SHAPE能够获取患者的观点和临床数据,从而为监管机构、临床医生、研究人员和患者权益倡导组织提供数据,以指导药物研发并改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0e/9520400/8e341a8f4782/formative_v6i9e38579_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验